1st Quarter - Report · 2026

Filing UUID: 1dbdb5b7-f26a-453b-b2d0-7e2e5b8feb85
Type: Q1 — 1st Quarter - Report
Period: first_quarter
Year: 2026
Posted: 2026-04-16 15:02:23
Income (reported): $20,000
Expenses (reported): —
Filing document: Open on lda.senate.gov

Registrant (lobbying firm)

HOLLAND & KNIGHT LLP

Law Firm

Contact: RICHARD GOLD
Phone: +1 202-955-3000
Address: zip:20006, city:Washington, state:DC, street:800 17th Street NW Suite 1100

Client

UNITED MITOCHONDRIAL DISEASE FOUNDATION

Non-profit organization

State: PA
Country: US
Government-entity client: false
Effective date: 2009-02-01

Issues lobbied + lobbyists

`HCR` — Health Issues

FY 2027 federal funding for DoD peer-reviewed medical research and the National Institutes of Health; Improvements in FDA rare disease New Drug Application review process; H.R. 5684 / S. 3304 - Medical Foods and Formulas Access Act.

Lobbyists: MIRANDA FRANCO; mr ROBERT HUNT BRADNER; SARAH STARLING CROSSAN (covered position: Staff Assistant, Sen. Lamar Alexander; Professional Staff, Health, Education, Labor, and Pensions (HELP) Cmte.; Legislative Correspondent, Sen. Lamar Alexander) [new]; JORDAN BROSSI (covered position: Staff Asst., Leg. Cor., Sen. Tammy Baldwin; Leg. Cor., Sen. Joe Manchin; LA, Rep. Susie Lee; Health LA & Health Pol. Adv., Rep. Anna Eshoo,) [new]

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

`BUD` — Budget/Appropriations

FY 2027 federal funding for DoD peer-reviewed medical research and the National Institutes of Health.

Lobbyists: MIRANDA FRANCO; mr ROBERT HUNT BRADNER; SARAH STARLING CROSSAN [new]; JORDAN BROSSI [new]